Fluicell Osingo per osake

Mitä Fluicell tekee? Fluicell AB is a health care company headquartered in Moelndal, Sweden. It provides fluid platforms for multi-functional pipettes used in cell-based pharmacology research. The company commercializes products including the BioPen and Dynaflow Resolve for processing and studying individual cells, primarily in drug development. It also develops bioprinting technology called Biopixlar Retina, which creates complex tissue-like structures with control over individual cell positioning in both 2D and 3D formats. Fluicell AB completed its IPO on April 18, 2018. Fluicell on yksi Eurpooliin suosituimmista yhtiöistä.